Mucosal cytokine imbalance in irritable bowel syndrome

Functional Bowel Disorders

Longstreth, G. F., Thompson, W. G., Chey, W. D., Houghton, L. A., Mearin, F., & Spiller, R. C. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.11.061 · Cited by 4,856 · see citing works

Functional bowel disorders and functional abdominal pain

Thompson, W. G., Longstreth, G. F., Drossman, D. A., Heaton, K. W., Irvine, E. J., & Müller-Lissner, S. A. (1999) · Gut · doi:10.1136/gut.45.2008.ii43 · Cited by 2,440 · see citing works

Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome

Barbara, G., Stanghellini, V., De Giorgio, R., Cremon, C., Cottrell, G. S., Santini, D., Pasquinelli, G., Morselli-Labate, A. M., Grady, E. F., Bunnett, N. W., et al. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.11.055 · Cited by 1,475 · see citing works

Lactobacillus and bifidobacterium in irritable bowel syndrome: Symptom responses and relationship to cytokine profiles

O’Mahony, L., McCarthy, J., Kelly, P., Hurley, G., Luo, F., Chen, K., O’Sullivan, G. C., Kiely, B., Collins, J. K., Shanahan, F., et al. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.11.050 · Cited by 1,448 · see citing works

Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute <i>Campylobacter</i> enteritis and in post-dysenteric irritable bowel syndrome

Spiller, R. C., Jenkins, D., Thornley, J. P., Hebden, J. M., Wright, T., Skinner, M., & Neal, K. R. (2000) · Gut · doi:10.1136/gut.47.6.804 · Cited by 1,155 · see citing works

Postinfectious Irritable Bowel Syndrome

Spiller, R., & Garsed, K. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.02.074 · Cited by 1,024 · see citing works

The Fecal Microbiota of Irritable Bowel Syndrome Patients Differs Significantly From That of Healthy Subjects

Kassinen, A., Krogius-Kurikka, L., Mäkivuokko, H., Rinttilä, T., Paulin, L., Corander, J., Malinen, E., Apajalahti, J., & Palva, A. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.04.005 · Cited by 1,002 · see citing works

Activation of the mucosal immune system in irritable bowel syndrome

Chadwick, V. S., Chen, W., Shu, D., Paulus, B., Bethwaite, P., Tie, A., & Wilson, I. (2002) · Gastroenterology · doi:10.1053/gast.2002.33579 · Cited by 833 · see citing works

Efficacy of an Encapsulated Probiotic Bifidobacterium infantis 35624 in Women with Irritable Bowel Syndrome

Whorwell, P. J., Altringer, L., Morel, J., Bond, Y., Charbonneau, D., O'Mahony, L., Kiely, B., Shanahan, F., & Quigley, E. M. M. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00734.x · Cited by 799 · see citing works

The role of psychological and biological factors in postinfective gut dysfunction

Gwee, K.-A., Leong, Y.-L., Graham, C., McKendrick, M. W., Collins, S. M., Walters, S. J., Underwood, J. E., & Read, N. W. (1999) · Gut · doi:10.1136/gut.44.3.400 · Cited by 764 · see citing works

Analysis of the Fecal Microbiota of Irritable Bowel Syndrome Patients and Healthy Controls with Real-Time PCR

Malinen, E., Rinttila, T., Kajander, K., Matto, J., Kassinen, A., Krogius, L., Saarela, M., Korpela, R., & Palva, A. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.40312.x · Cited by 699 · see citing works

Immune Activation in Patients With Irritable Bowel Syndrome

Liebregts, T., Adam, B., Bredack, C., Röth, A., Heinzel, S., Lester, S., Downie–Doyle, S., Smith, E., Drew, P., Talley, N. J., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.01.046 · Cited by 660 · see citing works

Hypothalamic-Pituitary-Gut Axis Dysregulation in Irritable Bowel Syndrome: Plasma Cytokines as a Potential Biomarker?

Dinan, T. G., Quigley, E. M. M., Ahmed, S. M. M., Scully, P., O’Brien, S., O’Mahony, L., O’Mahony, S., Shanahan, F., & Keeling, P. W. N. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.11.033 · Cited by 636 · see citing works

Epithelial cells as sensors for microbial infection.

Kagnoff, M. F., & Eckmann, L. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119522 · Cited by 619 · see citing works

Cytokines in intestinal inflammation: Pathophysiological and clinical considerations

Sartor, R. B. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90614-9 · Cited by 595 · see citing works

Role for protease activity in visceral pain in irritable bowel syndrome

Cenac, N., Andrews, C. N., Holzhausen, M., Chapman, K., Cottrell, G., Andrade-Gordon, P., Steinhoff, M., Barbara, G., Beck, P., Bunnett, N. W., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29255 · Cited by 591 · cited 1× · see citing works

Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS

Dunlop, S. P., Jenkins, D., Neal, K. R., & Spiller, R. C. (2003) · Gastroenterology · doi:10.1053/j.gastro.2003.09.028 · Cited by 583 · see citing works

Full-thickness biopsy of the jejunum reveals inflammation and enteric neuropathy in irritable bowel syndrome

Törnblom, H., Lindberg, G., Nyberg, B., & Veress, B. (2002) · Gastroenterology · doi:10.1053/gast.2002.37059 · Cited by 516 · see citing works

Many chemokines including CCL20/MIP-3α display antimicrobial activity

Yang, D., Chen, Q., Hoover, D. M., Staley, P. G., Tucker, K. D., Lubkowski, J. T., & Oppenheim, J. J. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.0103024 · Cited by 464 · see citing works

Double blind, placebo controlled trial of two probiotic strains in interleukin 10 knockout mice and mechanistic link with cytokine balance

McCarthy, J., O’Mahony, L., O’Callaghan, L., Sheil, B., Vaughan, E. E., Fitzsimons, N., Fitzgibbon, J., O’Sullivan, G. C., Kiely, B., Collins, J. K., et al. (2003) · Gut · doi:10.1136/gut.52.7.975 · Cited by 462 · see citing works

Increased rectal mucosal expression of interleukin 1beta in recently acquired post-infectious irritable bowel syndrome

Gwee, K.-A. (2003) · Gut · doi:10.1136/gut.52.4.523 · Cited by 415 · see citing works

Diarrhoea-predominant IBS patients show mast cell activation and hyperplasia in the jejunum

Guilarte, M., Santos, J., de Torres, I., Alonso, C., Vicario, M., Ramos, L., Martinez, C., Casellas, F., Saperas, E., & Malagelada, J. R. (2007) · Gut · doi:10.1136/gut.2006.100594 · Cited by 385 · see citing works

Postinfectious irritable bowel syndrome1 1Abbreviations used in this paper: EC,_; IBS, irritable bowel syndrome; PI, postinfective.

Spiller, R. E. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00324-x · Cited by 353 · see citing works

Postinfectious Irritable Bowel Syndrome-A Meta-Analysis

Halvorson, H. A., Schlett, C. D., & Riddle, M. S. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00654.x · Cited by 352 · see citing works

A Randomized Double-Blind Placebo-Controlled Trial of Rifaximin in Patients with Abdominal Bloating and Flatulence

Sharara, A. I., Aoun, E., Abdul-Baki, H., Mounzer, R., Sidani, S., & ElHajj, I. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00458.x · Cited by 344 · see citing works

Gene expression levels assessed by oligonucleotide microarray analysis and quantitative real-time RT-PCR – how well do they correlate?

Dallas, P. B., Gottardo, N. G., Firth, M. J., Beesley, A. H., Hoffmann, K., Terry, P. A., Freitas, J. R., Boag, J. M., Cummings, A. J., & Kees, U. R. (2005) · BMC Genomics · doi:10.1186/1471-2164-6-59 · Cited by 341 · see citing works

Composition and temporal stability of gastrointestinal microbiota in irritable bowel syndrome – a longitudinal study in IBS and control subjects

Mättö, J., Maunuksela, L., Kajander, K., Palva, A., Korpela, R., Kassinen, A., & Saarela, M. (2005) · FEMS Immunology &amp; Medical Microbiology · doi:10.1016/j.femsim.2004.08.009 · Cited by 301 · see citing works

Interleukin 10 genotypes in irritable bowel syndrome: evidence for an inflammatory component?: Table 1

Gonsalkorale, W. M., Perrey, C., Pravica, V, Whorwell, P. J., & Hutchinson, I. V. (2003) · Gut · doi:10.1136/gut.52.1.91 · Cited by 273 · see citing works

Intestinal microecology and quality of life in irritable bowel syndrome patients

Si, J.-M. (2004) · World Journal of Gastroenterology · doi:10.3748/wjg.v10.i12.1802 · Cited by 218 · see citing works

Role of Tumor Necrosis Factor-alpha and Interleukin-10 Gene Polymorphisms in Irritable Bowel Syndrome

van der Veek, P. P. J., van den Berg, M., de Kroon, Y. E., Verspaget, H. W., & Masclee, A. A. M. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.00257.x · Cited by 217 · see citing works

Prevalence and temporal stability of selected clostridial groups in irritable bowel syndrome in relation to predominant faecal bacteria

Maukonen, J., Satokari, R., Mättö, J., Söderlund, H., Mattila-Sandholm, T., & Saarela, M. (2006) · Journal of Medical Microbiology · doi:10.1099/jmm.0.46134-0 · Cited by 156 · see citing works

Irritable bowel syndrome: The burden and unmet needs in Europe

Quigley, E. M. M., Bytzer, P. M., Jones, R. H., & Mearin, F. (2006) · Digestive and Liver Disease · doi:10.1016/j.dld.2006.05.009 · Cited by 108 · see citing works

A Controlled Study of Colonic Immune Activity and β7+ Blood T Lymphocytes in Patients With Irritable Bowel Syndrome

Öhman, L., Isaksson, S., Lundgren, A., Simrén, M., & Sjövall, H. (2005) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(05)00410-6 · Cited by 98 · see citing works

Bacterial flora in irritable bowel syndrome: role in pathophysiology, implications for management

Quigley, E. M. M. (2007) · Journal of Digestive Diseases · doi:10.1111/j.1443-9573.2007.00277.x · Cited by 67 · see citing works

Instability in the faecal flora of a patient suffering from food-related irritable bowel syndrome

BRADLEY, H. K., Wyatt, G. M., Bayliss, C. E., & HUNTER, J. O. (1987) · Journal of Medical Microbiology · doi:10.1099/00222615-23-1-29 · Cited by 65 · see citing works

Identification of CD7 as a Cognate of the Human K12 (SECTM1) Protein

Lyman, S. D., Escobar, S. M., Rousseau, A.-M., Armstrong, A. J., & Fanslow, W. C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.5.3431 · Cited by 49 · see citing works

CD4+CD25+ regulatory T cells in irritable bowel syndrome patients

Holmén, N., Isaksson, S., Simrén, M., Sjövall, H., & Öhman, L. (2006) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2006.00878.x · Cited by 38 · see citing works

Dual Function of Interleukin-1β for the Regulation of Interleukin-6-induced Suppressor of Cytokine Signaling 3 Expression

Yang, X., Albrecht, U., Zakowski, V., Sobota, R. M., Häussinger, D., Heinrich, P. C., Ludwig, S., Bode, J. G., & Schaper, F. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313072200 · Cited by 26 · see citing works

Suppressive effect of Clostridium perfringens-produced heat-stable substance(s) on proliferation of human colon adenocarcinoma HT29 cells in culture

Arimochi, H., Morita, K., Kataoka, K., Nakanishi, S., Kuwahara, T., & Ohnishi, Y. (2005) · Cancer Letters · doi:10.1016/j.canlet.2005.10.016 · Cited by 13 · see citing works

The Economic Consequences of Irritable Bowel Syndrome

Leong, S. A., Barghout, V. E., Birnbaum, H. G., Thibeault, C., Ben-Hamadi, R., Frech, F. H., & Ofman, J. J. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.8.929

Efficacy of prebiotics, probiotics, and synbiotics in irritable bowel syndrome and chronic idiopathic constipation: systematic review and meta-analysis

Ford, A. C., Quigley, E. M. M., Lacy, B. E., Lembo, A. J., Saito, Y. A., Schiller, L. R., Soffer, E. E., Spiegel, B. M. R., & Moayyedi, P. (2014) · American Journal of Gastroenterology · doi:10.1038/ajg.2014.202 · Cited by 747 · see citing works

Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions

Öhman, L., & Simrén, M. (2010) · Nature Reviews Gastroenterology &amp; Hepatology · doi:10.1038/nrgastro.2010.4 · Cited by 617 · see citing works

The mucosal immune system: master regulator of bidirectional gut-brain communications

Powell, N., Walker, M. M., & Talley, N. J. (2017) · Nature Reviews Gastroenterology &amp; Hepatology · doi:10.1038/nrgastro.2016.191 · Cited by 379 · see citing works

A role for the gut microbiota in IBS

Collins, S. M. (2014) · Nature Reviews Gastroenterology &amp; Hepatology · doi:10.1038/nrgastro.2014.40 · Cited by 351 · see citing works

Activation of Human Enteric Neurons by Supernatants of Colonic Biopsy Specimens From Patients With Irritable Bowel Syndrome

Buhner, S., Li, Q., Vignali, S., Barbara, G., De Giorgio, R., Stanghellini, V., Cremon, C., Zeller, F., Langer, R., Daniel, H., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.07.005 · Cited by 351 · see citing works

Gastrointestinal microbiota in irritable bowel syndrome: present state and perspectives

Salonen, A., de Vos, W. M., & Palva, A. (2010) · Microbiology · doi:10.1099/mic.0.043257-0 · Cited by 264 · see citing works

Irritable Bowel Syndrome–Type Symptoms in Patients With Inflammatory Bowel Disease: A Real Association or Reflection of Occult Inflammation?

Keohane, J., O’Mahony, C., O’Mahony, L., O’Mahony, S. M., Quigley, E. M. M., & Shanahan, F. (2010) · The American Journal of Gastroenterology · doi:10.1038/ajg.2010.156 · Cited by 254 · see citing works

Dysregulation of the hypothalamic‐pituitary‐adrenal (HPA) axis in irritable bowel syndrome

Chang, L., Sundaresh, S., Elliott, J. E., Anton, P. A., Baldi, P., Licudine, A., Mayer, M., Vuong, T., Hirano, M., Naliboff, B. D., et al. (2008) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2008.01171.x · Cited by 250 · see citing works

Use of probiotics in gastrointestinal disorders: what to recommend?

Verna, E. C., & Lucak, S. L. (2010) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x10373814 · Cited by 242 · see citing works

S3-Leitlinie Reizdarmsyndrom: Definition, Pathophysiologie, Diagnostik und Therapie. Gemeinsame Leitlinie der Deutschen Gesellschaft für Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Neurogastroenterologie und Motilität (DGNM)

Layer, P., Andresen, V., Pehl, C., Allescher, H. ‐., Bischoff, S., Claßen, M., Enck, P., Frieling, T., Haag, S., Holtmann, G., et al. (2011) · Zeitschrift für Gastroenterologie · doi:10.1055/s-0029-1245976 · Cited by 231 · see citing works

The Jejunum of Diarrhea-Predominant Irritable Bowel Syndrome Shows Molecular Alterations in the Tight Junction Signaling Pathway That Are Associated With Mucosal Pathobiology and Clinical Manifestations

Martínez, C., Vicario, M., Ramos, L., Lobo, B., Mosquera, J. L., Alonso, C., Sánchez, A., Guilarte, M., Antolín, M., de Torres, I., et al. (2012) · American Journal of Gastroenterology · doi:10.1038/ajg.2011.472 · Cited by 214 · see citing works

The influence of the gut microbiome on obesity, metabolic syndrome and gastrointestinal disease

Parekh, P. J., Balart, L. A., & Johnson, D. A. (2015) · Clinical and Translational Gastroenterology · doi:10.1038/ctg.2015.16 · Cited by 219 · see citing works

Review article: associations between immune activation, intestinal permeability and the irritable bowel syndrome

Matricon, J., Méleine, M., Gelot, A., Piche, T., Dapoigny, M. C., Muller, E., & Ardid, D. (2012) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12080 · Cited by 216 · see citing works

The immune system in irritable bowel syndrome

Barbara, G., Cremon, C., Carini, G., Bellacosa, L., Zecchi, L., Giorgio, R. D., Corinaldesi, R., & Stanghellini, V. (2011) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm.2011.17.4.349 · Cited by 211 · see citing works

Differential Expression of Toll-Like Receptors in Patients With Irritable Bowel Syndrome

Brint, E. K., MacSharry, J., Fanning, A., Shanahan, F., & Quigley, E. M. M. (2011) · American Journal of Gastroenterology · doi:10.1038/ajg.2010.438 · Cited by 205 · see citing works

Mucosal inflammation as a potential etiological factor in irritable bowel syndrome: a systematic review

Ford, A. C., & Talley, N. J. (2011) · Journal of Gastroenterology · doi:10.1007/s00535-011-0379-9 · Cited by 200 · see citing works

Histamine and gut mucosal immune regulation

Smolińska, S., Jutel, M., Crameri, R., & O’Mahony, L. (2013) · Allergy · doi:10.1111/all.12330 · Cited by 199 · see citing works

Clinical significance of lymph node metastasis in gastric cancer

Deng, J. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i14.3967 · Cited by 198 · see citing works

Irritable bowel syndrome: towards biomarker identification

Clarke, G. A., Quigley, E. M. M., Cryan, J. F., & Dinan, T. G. (2009) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2009.08.001 · Cited by 180 · see citing works

The epithelial barrier theory and its associated diseases

Sun, N., Öğülür, İ., Mitamura, Y., Yazıcı, D., Pat, Y., Bu, X., Li, M., Zhu, X., Babayev, H., Ardıçlı, S., et al. (2024) · Allergy · doi:10.1111/all.16318 · Cited by 188 · see citing works

Cytokine imbalance in irritable bowel syndrome: a systematic review and meta‐analysis

Bashashati, M., Rezaei, N., Shafieyoun, A., McKernan, D. P., Chang, L., Öhman, L., Quigley, E. M. M., Schmulson, M. J., Sharkey, K. A., & Simrén, M. (2014) · Neurogastroenterology & Motility · doi:10.1111/nmo.12358 · Cited by 173 · see citing works

Mast cell–nerve axis with a focus on the human gut

Bühner, S., & Schemann, M. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.06.004 · Cited by 151 · see citing works

Portrait of an immunoregulatory bifidobacterium

Konieczna, P., Akdiş, C. A., Quigley, E. M. M., Shanahan, F., & O’Mahony, L. (2012) · Gut Microbes · doi:10.4161/gmic.20358 · Cited by 150 · see citing works

Serum and Colonic Mucosal Immune Markers in Irritable Bowel Syndrome

Chang, L., Adeyemo, M. A., Karagiannidis, I., Videlock, E. J., Bowe, C., Shih, W., Presson, A. P., Yuan, P., Cortina, G. R., Gong, H., et al. (2011) · The American Journal of Gastroenterology · doi:10.1038/ajg.2011.423 · Cited by 148 · see citing works

Immune Activation in Irritable Bowel Syndrome: Can Neuroimmune Interactions Explain Symptoms?

Hughes, P. A., Zola, H., Penttila, I., Blackshaw, L. A., Andrews, J. M., & Krumbiegel, D. (2013) · The American Journal of Gastroenterology · doi:10.1038/ajg.2013.120 · Cited by 147 · see citing works

Evidence for Local and Systemic Immune Activation in Functional Dyspepsia and the Irritable Bowel Syndrome: A Systematic Review

Burns, G., Carroll, G., Mathe, A., Horvat, J., Foster, P., Walker, M. M., Talley, N. J., & Keely, S. (2019) · American Journal of Gastroenterology · doi:10.1038/s41395-018-0377-0 · Cited by 145 · see citing works

miR-16 and miR-125b are involved in barrier function dysregulation through the modulation of claudin-2 and cingulin expression in the jejunum in IBS with diarrhoea

Martínez, C., Rodiño‐Janeiro, B. K., Lobo, B., Stanifer, M. L., Klaus, B., Granzow, M., González-Castro, A. M., Salvo‐Romero, E., Alonso, C., Pigrau, M., et al. (2017) · Gut · doi:10.1136/gutjnl-2016-311477 · Cited by 143 · see citing works

Mechanisms Underlying Visceral Hypersensitivity in Irritable Bowel Syndrome

Barbara, G., Cremon, C., GIORGIO, R. D., Dothel, G., Zecchi, L., Bellacosa, L., Carini, G., Stanghellini, V., & Corinaldesi, R. (2011) · Current Gastroenterology Reports · doi:10.1007/s11894-011-0195-7 · Cited by 144 · see citing works

Irritable Bowel Syndrome: Methods, Mechanisms, and Pathophysiology. Neural and neuro-immune mechanisms of visceral hypersensitivity in irritable bowel syndrome

Feng, B., La, J., Schwartz, E. S., & Gebhart, G. F. (2012) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00542.2011 · Cited by 141 · see citing works

Gut Microbiota as Potential Orchestrators of Irritable Bowel Syndrome

Bennet, S., Öhman, L., & Simrén, M. (2015) · Gut and Liver · doi:10.5009/gnl14344 · Cited by 143 · see citing works

Do interactions between stress and immune responses lead to symptom exacerbations in irritable bowel syndrome?

O’Malley, D., Quigley, E. M. M., Dinan, T. G., & Cryan, J. F. (2011) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2011.04.009 · Cited by 139 · see citing works

Ameliorating effects and mechanisms of transcutaneous auricular vagal nerve stimulation on abdominal pain and constipation

Shi, X., Hu, Y., Zhang, B., Li, W., Chen, J. D., & Liu, F. (2021) · JCI Insight · doi:10.1172/jci.insight.150052 · Cited by 134 · see citing works

Complementary and alternative medicines in irritable bowel syndrome: An integrative view

Grundmann, O. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i2.346 · Cited by 121 · see citing works

Global Cytokine Profiles and Association With Clinical Characteristics in Patients With Irritable Bowel Syndrome

Bennet, S., Polster, A. V., Törnblom, H., Isaksson, S., Capronnier, S., Tessier, A., Nevé, B. L., Simrén, M., & Öhman, L. (2016) · The American Journal of Gastroenterology · doi:10.1038/ajg.2016.223 · Cited by 116 · see citing works

Intestinal microbiota and immune function in the pathogenesis of irritable bowel syndrome

Ringel, Y., & Maharshak, N. (2013) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00207.2012 · Cited by 115 · see citing works

Recent developments in the pathophysiology of irritable bowel syndrome

El-Salhy, M. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i25.7621 · Cited by 111 · see citing works

Post-infectious irritable bowel syndrome: Mechanistic insights into chronic disturbances following enteric infection

Beatty, J. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i14.3976 · Cited by 107 · see citing works

Intestinal microbiota in pathophysiology and management of irritable bowel syndrome.

(2014) · PubMed Central · doi:10.3748/wjg.v20.i27.8886 · Cited by 106 · see citing works

Low-grade inflammation plays a pivotal role in gastrointestinal dysfunction in irritable bowel syndrome

Akiho, H. (2010) · World Journal of Gastrointestinal Pathophysiology · doi:10.4291/wjgp.v1.i3.97 · Cited by 109 · see citing works

Inflammatory bowel disease, irritable bowel syndrome, or what: a challenge to the functional-organic dichotomy.

Long, M. D., & Drossman, D. A. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2010.162 · Cited by 101 · see citing works

Increasing Evidence That Irritable Bowel Syndrome and Functional Gastrointestinal Disorders Have a Microbial Pathogenesis

Carco, C., Young, W., Gearry, R. B., Talley, N. J., McNabb, W. C., & Roy, N. C. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00468 · Cited by 97 · see citing works

Mucosal Immune Cell Numbers and Visceral Sensitivity in Patients With Irritable Bowel Syndrome: Is There Any Relationship?

Braak, B., Klooker, T. K., Wouters, M. M., Welting, O., van der Loos, C. M., Stanisor, O. I., van Diest, S., van den Wijngaard, R. M., & Boeckxstaens, G. E. (2012) · American Journal of Gastroenterology · doi:10.1038/ajg.2012.54 · Cited by 93 · see citing works

Histamine: A Mediator of Intestinal Disorders—A Review

Smolińska, S., Winiarska, E., Głobińska, A., & Jutel, M. (2022) · Metabolites · doi:10.3390/metabo12100895 · Cited by 95 · see citing works

Overlapping irritable bowel syndrome and inflammatory bowel disease: less to this than meets the eye?

Quigley, E. M. M. (2015) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x15621230 · Cited by 86 · see citing works

The efficacy and safety of probiotics in patients with irritable bowel syndrome: Evidence based on 35 randomized controlled trials

Niu, H.-L., & Xiao, J. (2020) · International Journal of Surgery · doi:10.1016/j.ijsu.2020.01.142 · Cited by 86 · see citing works

Mucosal Permeability and Immune Activation as Potential Therapeutic Targets of Probiotics in Irritable Bowel Syndrome

Barbara, G., Zecchi, L., Barbaro, M. R., Cremon, C., Bellacosa, L., Marcellini, M. M., GIORGIO, R. D., Corinaldesi, R., & Stanghellini, V. (2012) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e318264e918 · Cited by 79 · see citing works

Serum immune biomarkers in irritable bowel syndrome

Seyedmirzaee, S., Hayatbakhsh, M. M., Ahmadi, B., Baniasadi, N., Rafsanjani, A. M. B., Nikpoor, A. R., & Mohammadi, M. (2016) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2015.12.013 · Cited by 78 · see citing works

Risk of inflammatory bowel disease following a diagnosis of irritable bowel syndrome

Porter, C. K., Cash, B. D., Pimentel, M., Akinseye, A., & Riddle, M. S. (2012) · BMC Gastroenterology · doi:10.1186/1471-230x-12-55 · Cited by 76 · see citing works

Cytokines and irritable bowel syndrome: Where do we stand?

Bashashati, M., Rezaei, N., Andrews, C. N., Chen, C., Daryani, N. E., Sharkey, K. A., & Storr, M. (2011) · Cytokine · doi:10.1016/j.cyto.2011.11.019 · Cited by 73 · see citing works

Colonic soluble mediators from the maternal separation model of irritable bowel syndrome activate submucosal neurons via an interleukin-6-dependent mechanism

O’Malley, D., Liston, M., Hyland, N. P., Dinan, T. G., & Cryan, J. F. (2010) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00385.2010 · Cited by 73 · see citing works

Effect of Red Pepper on Symptoms of Irritable Bowel Syndrome: Preliminary Study

Bortolotti, M., & Porta, S. (2011) · Digestive Diseases and Sciences · doi:10.1007/s10620-011-1740-9 · Cited by 73 · see citing works

Pro-inflammatory and anti-inflammatory cytokine response in diarrhoea-predominant Irritable bowel syndrome patients

Rana, S., Sharma, S., Sk, S., Parsad, K., Malik, A., & Singh, K. (2012) · Tropical Gastroenterology · doi:10.7869/tg.2012.66 · Cited by 71 · see citing works

Current insights into the innate immune system dysfunction in irritable bowel syndrome

Lazaridis, N. (2018) · Annals of Gastroenterology · doi:10.20524/aog.2018.0229 · Cited by 75 · see citing works

Therapies Aimed at the Gut Microbiota and Inflammation: Antibiotics, Prebiotics, Probiotics, Synbiotics, Anti-inflammatory Therapies

Quigley, E. M. M. (2011) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2010.12.009 · Cited by 67 · see citing works

Toll-Like Receptor mRNA Expression Is Selectively Increased in the Colonic Mucosa of Two Animal Models Relevant to Irritable Bowel Syndrome

McKernan, D. P., Nolan, A. M., Brint, E. K., O’Mahony, S. M., Hyland, N. P., Cryan, J. F., & Dinan, T. G. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008226 · Cited by 70 · see citing works

Lower Serum IL-10 Is an Independent Predictor of IBS Among Volunteers in Mexico

Schmulson, M. J., Pulido-London, D., Rodríguez, Ó., Rochilin, N. M., Martínez-García, R., Gutiérrez‐Ruíz, M. C., López-Alvarenga, J. C., Robles‐Díaz, G., & Gutiérrez‐Reyes, G. (2012) · The American Journal of Gastroenterology · doi:10.1038/ajg.2011.484 · Cited by 64 · see citing works

Marked elevations in pro-inflammatory polyunsaturated fatty acid metabolites in females with irritable bowel syndrome

Clarke, G. A., Fitzgerald, P., Hennessy, A. A., Cassidy, E., Quigley, E. M. M., Ross, R. P., Stanton, C., Cryan, J. F., & Dinan, T. G. (2009) · Journal of Lipid Research · doi:10.1194/jlr.p000695 · Cited by 63 · see citing works

The efficacy and safety of probiotics for patients with constipation-predominant irritable bowel syndrome: A systematic review and meta-analysis based on seventeen randomized controlled trials

Wen, Y., Li, J., Long, Q., Yue, C.-C., He, B., & Tang, X.-G. (2020) · International Journal of Surgery · doi:10.1016/j.ijsu.2020.04.063 · Cited by 62 · see citing works

Probiotics in functional gastrointestinal disorders: what are the facts?

Quigley, E. M. M. (2008) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2008.08.007 · Cited by 61 · see citing works

Musosal tumour necrosis factor α in diverticular disease of the colon is overexpressed with disease severity

Tursi, A., Elisei, W., Brandimarte, G., Giorgetti, G. M., Inchingolo, C. D., Nenna, R., Picchio, M., Giorgio, F., & Ierardi, E. (2012) · Colorectal Disease · doi:10.1111/j.1463-1318.2012.02926.x · Cited by 60 · see citing works

Cytokine gene polymorphisms are associated with irritable bowel syndrome: a systematic review and meta‐analysis

Bashashati, M., Rezaei, N., Bashashati, H., Shafieyoun, A., Daryani, N. E., Sharkey, K. A., & Storr, M. (2012) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2012.01990.x · Cited by 60 · see citing works

The Efficacy of Probiotics, Prebiotics, Synbiotics, and Fecal Microbiota Transplantation in Irritable Bowel Syndrome: A Systematic Review and Network Meta-Analysis

Wu, Y., Li, Y., Zheng, Q., & Li, L. (2024) · Nutrients · doi:10.3390/nu16132114 · Cited by 66 · see citing works

Immune response in irritable bowel syndrome: A systematic review of systemic and mucosal inflammatory mediators

Martin‐Viñas, J. J., & Quigley, E. M. M. (2016) · Journal of Digestive Diseases · doi:10.1111/1751-2980.12379 · Cited by 57 · see citing works

Immune derived opioidergic inhibition of viscerosensory afferents is decreased in Irritable Bowel Syndrome patients

Hughes, P. A., Moretta, M., Lim, A. H. W., Grasby, D. J., Bird, D., Brierley, S. M., Liebregts, T., Adam, B., Blackshaw, L. A., Holtmann, G., et al. (2014) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2014.07.001 · Cited by 55 · see citing works

Convergence of neuro-endocrine-immune pathways in the pathophysiology of irritable bowel syndrome.

Buckley, M. M., O’Mahony, S. M., & O’Malley, D. (2014) · PubMed Central · doi:10.3748/wjg.v20.i27.8846 · Cited by 55 · see citing works

Pathogenesis of Irritable Bowel Syndrome - Review Regarding Associated Infection and Immune Activation

Ishihara, S., Tada, Y., Fukuba, N., Oka, A., Kusunoki, R., Mishima, Y., Oshima, N., Moriyama, I., Yuki, T., Kawashima, K., et al. (2013) · Digestion · doi:10.1159/000350054 · Cited by 51 · see citing works

Disruption of the pro-inflammatory, anti-inflammatory cytokines and tight junction proteins expression, associated with changes of the composition of the gut microbiota in patients with irritable bowel syndrome

Ivashkin, V., Poluektov, Y., Kogan, E., Shifrin, O., Sheptulin, A., Kovaleva, A., Kurbatova, A., Krasnov, G., & Poluektova, E. (2021) · PLOS ONE · doi:10.1371/journal.pone.0252930 · Cited by 51 · see citing works

Submucous rather than myenteric neurons are activated by mucosal biopsy supernatants from irritable bowel syndrome patients

Bühner, S., Li, Q., Berger, T., Vignali, S., Barbara, G., GIORGIO, R. D., Stanghellini, V., & Schemann, M. (2012) · Neurogastroenterology & Motility · doi:10.1111/nmo.12011 · Cited by 50 · see citing works

Interferon-γ is increased in the gut of patients with irritable bowel syndrome and modulates serotonin metabolism

Barbaro, M. R., Sabatino, A. D., Cremon, C., Giuffrida, P., Fiorentino, M., Altimari, A., Bellacosa, L., Stanghellini, V., & Barbara, G. (2016) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00368.2015 · Cited by 50 · see citing works

Irritable bowel syndrome immune hypothesis: Part two: the role of cytokines

Lucas, M. O., Peiró, P. S., & Domingo, J. J. S. (2010) · Revista Española de Enfermedades Digestivas · doi:10.4321/s1130-01082010001200006 · Cited by 48 · see citing works

From Cytokines to Toll-Like Receptors and Beyond - Current Knowledge and Future Research Needs in Irritable Bowel Syndrome

Rodríguez, Ó., Hernández-Ruiz, J., & Schmulson, M. J. (2010) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm.2010.16.4.363 · Cited by 48 · see citing works

What does irritable bowel syndrome share with non-alcoholic fatty liver disease?

Scalera, A. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i33.5402 · Cited by 48 · see citing works

The overlap between IBS and IBD – what is it and what does it mean?

Stanišić, V., & Quigley, E. M. M. (2014) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2014.876361 · Cited by 41 · see citing works

Berberine prevents stress-induced gut inflammation and visceral hypersensitivity and reduces intestinal motility in rats

Yu, Z., Cen, Y.-X., Wu, B.-H., Cheng, W., Xiong, F., Li, D., Liu, T.-T., Luo, M., Guo, L., Li, Y., et al. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i29.3956 · Cited by 41 · see citing works

The T/NK cell co-stimulatory molecule SECTM1 is an IFN “early response gene” that is negatively regulated by LPS in Human monocytic cells

Huyton, T., Göttmann, W., Bade‐Doeding, C., Paine, A., & Blasczyk, R. (2011) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2011.06.020 · Cited by 40 · see citing works

Putative mechanisms of kiwifruit on maintenance of normal gastrointestinal function

Bayer, S. B., Gearry, R. B., & Drummond, L. (2017) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2017.1327841 · Cited by 40 · see citing works

Neuroimmune factors in functional gastrointestinal disorders: A focus on irritable bowel syndrome

Boeckxstaens, G., & Wouters, M. (2017) · Neurogastroenterology and Motility · doi:10.1111/nmo.13007 · Cited by 36 · see citing works

Interleukin-10: A Compelling Therapeutic Target in Patients With Irritable Bowel Syndrome

Kumar, S., Shukla, R., Ranjan, P., & Kumar, A. (2017) · Clinical Therapeutics · doi:10.1016/j.clinthera.2017.01.030 · Cited by 38 · see citing works

Latest Insights on the Pathogenesis of Irritable Bowel Syndrome

Videlock, E. J., & Chang, L. (2021) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2021.04.002 · Cited by 38 · see citing works

Biomarkers in IBS: when will they replace symptoms for diagnosis and management?: Table 1

Barbara, G., & Stanghellini, V. (2009) · Gut · doi:10.1136/gut.2008.169672 · Cited by 37 · see citing works

Altered levels of cytokines in patients with irritable bowel syndrome are not correlated with fatigue

Vara, E. J., Brokstad, K. A., Hausken, T., & Lied, G. A. (2018) · International Journal of General Medicine · doi:10.2147/ijgm.s166600 · Cited by 37 · see citing works

Targeted therapy of irritable bowel syndrome with anti-inflammatory cytokines

Kumar, S., Singh, P., & Kumar, A. (2021) · Clinical Journal of Gastroenterology · doi:10.1007/s12328-021-01555-8 · Cited by 35 · see citing works

Editorial: Abnormal Immune Regulation and Low-Grade Inflammation in IBS: Does One Size Fit All?

Schmulson, M. J., & Chey, W. D. (2012) · The American Journal of Gastroenterology · doi:10.1038/ajg.2011.427 · Cited by 34 · see citing works

Impaired Intestinal Permeability of Tricellular Tight Junctions in Patients with Irritable Bowel Syndrome with Mixed Bowel Habits (IBS-M)

Awad, K., Barmeyer, C., Bojarski, C., Nagel, O., Lee, I.-F. M., Schweiger, M. R., Schulzke, J., & Bücker, R. (2023) · Cells · doi:10.3390/cells12020236 · Cited by 33 · see citing works

Crosstalk between interleukin-6 and corticotropin-releasing factor modulate submucosal plexus activity and colonic secretion

O’Malley, D., Cryan, J. F., & Dinan, T. G. (2013) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2013.01.078 · Cited by 33 · see citing works

Altered expression and secretion of colonic Interleukin-6 in a stress-sensitive animal model of brain-gut axis dysfunction

O’Malley, D., Dinan, T. G., & Cryan, J. F. (2011) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2011.04.003 · Cited by 33 · see citing works

The Colonic Tissue Levels of TLR2, TLR4 and Nitric Oxide in Patients with Irritable Bowel Syndrome

ak, E. K. C., Akbal, E., Köklü, S., l, B. E. U., & Can, M. (2016) · Internal Medicine · doi:10.2169/internalmedicine.55.5716 · Cited by 32 · see citing works

Histamine-producing bacteria and their role in gastrointestinal disorders

Fiorani, M., Vecchio, L. E. D., D’Argenio, P., Kaitsas, F., Rozera, T., Porcari, S., Gasbarrini, A., Cammarota, G., & Ianiro, G. (2023) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2023.2230865 · Cited by 32 · see citing works

Elevated expression of c-fos in central nervous system correlates with visceral hypersensitivity in irritable bowel syndrome (IBS): a new target for IBS treatment

Zhang, R., Zou, N., Li, J., Lv, H., Wei, J., Fang, X., & Qian, J. (2011) · International Journal of Colorectal Disease · doi:10.1007/s00384-011-1153-4 · Cited by 32 · see citing works

Expression of Neurotrophic Factors, Tight Junction Proteins, and Cytokines According to the Irritable Bowel Syndrome Subtype and Sex

Lee, J. Y., Kim, N., Park, J. H., Nam, R. H., Lee, S. M., Song, C., Kim, G., Na, H. Y., Choi, Y. J., Kim, J. J., et al. (2019) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm19099 · Cited by 31 · see citing works

Immunoglobulin E in irritable bowel syndrome: another target for treatment? A case report and literature review

Pearson, J. S., Niven, R. M., Meng, J., Atarodi, S., & Whorwell, P. J. (2015) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x15588875 · Cited by 29 · see citing works

Effects of red ginseng on gut, microbiota, and brain in a mouse model of post-infectious irritable bowel syndrome

Yu, S., Chun, E., Ji, Y., Lee, Y., & Jin, M. (2021) · Journal of Ginseng Research · doi:10.1016/j.jgr.2021.03.008 · Cited by 29 · see citing works

Interleukin-8 and -10 gene polymorphisms in irritable bowel syndrome

Romero‐Valdovinos, M., Gudiño-Ramírez, A., Reyes-Gordillo, J., Martínez-Flores, W. A., Ramírez-Miranda, M. E., Maravilla, P., & Olivo‐Díaz, A. (2012) · Molecular Biology Reports · doi:10.1007/s11033-012-1745-2 · Cited by 28 · see citing works

Therapeutic Modulation of Gut Microbiota in Functional Bowel Disorders

Lee, H. J., Choi, J., Ryu, H. S., Choi, C. H., Kang, E. H., Park, K. S., Min, Y. W., & Hong, K. S. (2017) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm16124 · Cited by 28 · see citing works

Interleukin-6 Modulates Colonic Transepithelial Ion Transport in the Stress-Sensitive Wistar Kyoto Rat

O’Malley, D., Dinan, T. G., & Cryan, J. F. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00190 · Cited by 27 · see citing works

Increased Risk of Miscarriage and Ectopic Pregnancy Among Women With Irritable Bowel Syndrome

Khashan, A. S., Quigley, E. M. M., McNamee, R., McCarthy, F. P., Shanahan, F., & Kenny, L. C. (2012) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2012.02.014 · Cited by 27 · see citing works

Epithelial barrier dysfunction, type 2 immune response, and the development of chronic inflammatory diseases

Öğülür, İ., Pat, Y., Yazıcı, D., Ardıçlı, S., Ardıçlı, Ö., Mitamura, Y., Akdiş, M., & Akdiş, C. A. (2024) · Current Opinion in Immunology · doi:10.1016/j.coi.2024.102493 · Cited by 28 · see citing works

Clinical, endoscopical and morphological efficacy of mesalazine in patients with irritable bowel syndrome

Dorofeyev (2011) · Clinical and Experimental Gastroenterology · doi:10.2147/ceg.s18381 · Cited by 26 · see citing works

Evaluating the efficacy of mixture of Boswellia carterii, Zingiber officinale, and Achillea millefolium on severity of symptoms, anxiety, and depression in irritable bowel syndrome patients

Kazemian, A., Toghiani, A., Shafiei, K., Afshar, H., Rafiei, R., Memari, M., & Adibi, P. (2017) · Journal of Research in Medical Sciences · doi:10.4103/jrms.jrms_905_16 · Cited by 26 · see citing works

Aminosalicylates and Other Anti-Inflammatory Compounds for Irritable Bowel Syndrome

Barbara, G., Stanghellini, V., Cremon, C., GIORGIO, R. D., Fronzoni, L., Serra, M., & Corinaldesi, R. (2009) · Digestive Diseases · doi:10.1159/000268131 · Cited by 26 · see citing works

Mucosal Cytokine Imbalance in Irritable Bowel Syndrome (IBS)

Quigley, E. M. M., McSharry, J., O’Mahony, L., Fanning, A., Bairead, E., Scully, P., Tiesman, J. P., Fulmer, A. W., Dinan, T. G., Sherlock, G., et al. (2007) · The American Journal of Gastroenterology · doi:10.14309/00000434-200709002-01082 · Cited by 1 · see citing works

Irritable bowel syndrome immune hypothesis: Part two: the role of cytokines

Lucas, M. O., Peiró, P. S., & Domingo, J. J. S. (2010) · Revista Española de Enfermedades Digestivas · doi:10.4321/s1130-01082010001200006 · Cited by 48 · see citing works

Immune response in irritable bowel syndrome: A systematic review of systemic and mucosal inflammatory mediators

Martin‐Viñas, J. J., & Quigley, E. M. M. (2016) · Journal of Digestive Diseases · doi:10.1111/1751-2980.12379 · Cited by 57 · see citing works

Irritable bowel syndrome immune hypothesis: Part two: the role of cytokines Hipótesis inmune del síndrome del intestino irritable: Segunda parte: papel de las citokinas

Lucas, M. O., Peiró, P. S., & Domingo, J. J. S. (2010) · DOAJ (DOAJ: Directory of Open Access Journals)

T2074 The Expression of Toll-Like Receptor 4 in Colon Mucosa is as up-Regulated in Irritable Bowel Syndrome as it is in Inflammatory Bowel Disease

Dlugosz, A., & Lindberg, G. (2010) · Gastroenterology · doi:10.1016/s0016-5085(10)62887-9 · Cited by 2 · see citing works